Private Capital Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$5K Sell
171
-8
-4% -$273 ﹤0.01% 1248
2022
Q1
$7K Buy
179
+150
+517% +$6.62K ﹤0.01% 1385
2021
Q4
$1K Sell
29
-230
-89% -$10.4K ﹤0.01% 1920
2021
Q3
$13K Sell
259
-340
-57% -$20.6K ﹤0.01% 1248
2021
Q2
$38K Sell
599
-1,122
-65% -$72.1K 0.01% 784
2021
Q1
$160K Sell
1,721
-189
-10% -$19.4K 0.04% 254
2020
Q4
$171K Buy
1,910
+195
+11% +$17.9K 0.03% 346
2020
Q3
$177K Sell
1,715
-350
-17% -$37.7K 0.04% 303
2020
Q2
$163K Sell
2,065
-291
-12% -$21.7K 0.04% 314
2020
Q1
$136K Sell
2,356
-94
-4% -$5.42K 0.04% 335
2019
Q4
$132K Buy
2,450
+296
+14% +$16.1K 0.03% 370
2019
Q3
$113K Sell
2,154
-243
-10% -$11.3K 0.02% 442
2019
Q2
$121K Buy
2,397
+239
+11% +$11.5K 0.03% 331
2019
Q1
$109K Sell
2,158
-101
-4% -$5.96K 0.02% 436
2018
Q4
$134K Buy
2,259
+41
+2% +$2.64K 0.03% 310
2018
Q3
$146K Sell
2,218
-179
-7% -$10.4K 0.03% 323
2018
Q2
$121K Buy
2,397
+647
+37% +$33.7K 0.03% 356
2018
Q1
$92K Buy
1,750
+1,676
+2,265% +$83.5K 0.02% 437
2017
Q4
$1K Buy
+74
New +$3.12K ﹤0.01% 1926

Other funds holding EBS

Private Capital Group's EBS Position: Q2 2022 in Review

Private Capital Group reduced its Emergent Biosolutions (EBS) stake by 4.5% in Q2 2022, selling an estimated $273 and leaving 171 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

Private Capital Group first reported a position in EBS in Q4 2017 and has held it in 19 quarters since. The position peaked at $177K in Q3 2020. 231 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

  • Private Capital Group held 171 shares of Emergent Biosolutions worth $5K as of Q2 2022.
  • Private Capital Group sold 8 Emergent Biosolutions shares in Q2 2022, an estimated $273.
  • Emergent Biosolutions made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1248 holding.
  • Private Capital Group first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Emergent Biosolutions position peaked at $177K in Q3 2020.
  • 231 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.